Silver Book Fact

Without screening and adjuvant therapy, the death rate for breast cancer would have increased by about 30 percent between 1975 and 2000.

Berry, D, K Cronin, S Plevritis, D Fryback, L Clarke, et al. Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer. NEJM. 2005; 353(17): 84-92. http://www.nejm.org/doi/full/10.1056/NEJMoa050518

Reference

Title
Effect of Screening and Adjuvant Therapy on Mortality from Breast Cancer
Publication
NEJM
Publication Date
2005
Authors
Berry, D, K Cronin, S Plevritis, D Fryback, L Clarke, et al.
Volume & Issue
Volume 353, Issue 17
Pages
84-92
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Colorectal Cancer Screening: Trends, 2003-2006  
  • Cancer patients in the U.S. experience greater survival gains than those in European countries, and the value of additional gains exceeds the additional cost of care in the U.S.  
  • The use of imatinib (Gleevec) has increased the eight-year survival rate for early chronic-phase myelogenous leukemia from 65% to 84%.  
  • Treating cancer patients with oral medicine versus intravenous chemotherapy results in a 2/3 reduction in hospital time and a greater than 50% reduction in costly medication side effects.  
  • According to the Pharmaceutical Research and Manufacturers of America, a cancer medicine in development is designed to induce a powerful immune response to melanoma.